BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3183355)

  • 1. Plasma heparin cofactor II in alcoholic liver disease.
    Andersson TR; Bell H
    J Hepatol; 1988 Aug; 7(1):79-84. PubMed ID: 3183355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin cofactor II, antithrombin and protein C in plasma from term and preterm infants.
    Andersson TR; Bangstad H; Larsen ML
    Acta Paediatr Scand; 1988 Jul; 77(4):485-8. PubMed ID: 3394503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein C in patients with alcoholic cirrhosis and other liver diseases.
    Bell H; Odegaard OR; Andersson T; Raknerud N
    J Hepatol; 1992 Mar; 14(2-3):163-7. PubMed ID: 1500680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin cofactor II: a simple assay method and results of its clinical application.
    Vinazzer H; Pangraz U
    Thromb Res; 1987 Oct; 48(2):153-60. PubMed ID: 3424287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consumption of heparin cofactor II (dermatan sulfate cofactor) and antithrombin during coagulation.
    Andersson TR
    Thromb Res; 1987 Apr; 46(2):355-62. PubMed ID: 3603428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin cofactor II deficiency in the elderly: comparison with antithrombin III.
    Kario K; Matsuo T; Kobayashi H
    Thromb Res; 1992 Jun; 66(5):489-98. PubMed ID: 1381849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin cofactor II activity in plasma: application of an automated assay method to the study of a normal adult population.
    Andersson TR; Larsen ML; Handeland GF; Abildgaard U
    Scand J Haematol; 1986 Jan; 36(1):96-102. PubMed ID: 3754062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombin III and heparin cofactor II in patients with chronic renal failure undergoing regular hemodialysis.
    Toulon P; Jacquot C; Capron L; Frydman MO; Vignon D; Aiach M
    Thromb Haemost; 1987 Jun; 57(3):263-8. PubMed ID: 3660328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preferential consumption of heparin cofactor II in disseminated intravascular coagulation associated with acute promyelocytic leukemia.
    Kario K; Matsuo T; Kodama K; Katayama S; Kobayashi H
    Thromb Res; 1992 May; 66(4):435-44. PubMed ID: 1412208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of interference by heparin cofactor II in the DuPont aca antithrombin-III assay.
    Hortin GL; Tollefsen DM; Santoro SA
    Am J Clin Pathol; 1988 Apr; 89(4):515-7. PubMed ID: 3354504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Constitutional dysfunction of heparin cofactor II with a tendency for venous thrombosis].
    Marbet GA; Zbinden B; Duckert F
    Schweiz Med Wochenschr; 1988 Oct; 118(43):1586-8. PubMed ID: 3238395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma heparin cofactor II, protein C and antithrombin in elective surgery.
    Andersson TR; Berner NS; Larsen ML; Odegaard OR; Abildgaard U
    Acta Chir Scand; 1987 Apr; 153(4):291-6. PubMed ID: 3630527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methodology and clinical significance of heparin cofactor II. Probable heparin cofactor II deficiency in a patient with cerebrovascular thrombosis.
    Tran TH; Zbinden B; Lämmle B; Duckert F
    Semin Thromb Hemost; 1985 Oct; 11(4):342-6. PubMed ID: 3840916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of YKL-40 and PIIINP as prognostic markers in patients with alcoholic liver disease.
    Nøjgaard C; Johansen JS; Christensen E; Skovgaard LT; Price PA; Becker U;
    J Hepatol; 2003 Aug; 39(2):179-86. PubMed ID: 12873813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum laminin in chronic alcoholic liver disease: its value in the estimation of the degree of fibrosis].
    González Reimers E; Santolaria Fernández F; Rodríguez Rodríguez E; Rodríguez Moreno F; Milena Abril A; Martínez-Riera A; García-Castro C
    Rev Esp Enferm Dig; 1996 Apr; 88(4):241-5. PubMed ID: 9004793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assay of dermatan sulfate cofactor (heparin cofactor II) activity in human plasma.
    Abildgaard U; Larsen ML
    Thromb Res; 1984 Aug; 35(3):257-66. PubMed ID: 6547786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Turnover study of heparin cofactor II in healthy man.
    Sié P; Dupouy D; Pichon J; Boneu B
    Thromb Haemost; 1985 Oct; 54(3):635-8. PubMed ID: 3841420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The second cofactor of heparin].
    Sie P
    Ann Biol Clin (Paris); 1987; 45(2):181-3. PubMed ID: 3619144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin cofactor II in patients with deep venous thrombosis under heparin and oral anticoagulant therapy.
    Toulon P; Vitoux JF; Capron L; Roncato M; Fiessinger JN; Aiach M
    Thromb Res; 1988 Mar; 49(5):497-500. PubMed ID: 3376055
    [No Abstract]   [Full Text] [Related]  

  • 20. Purification and biological property of heparin cofactor II: activation of heparin cofactor II and antithrombin III by dextran sulfate and various glycosaminoglycans.
    Yamagishi R; Niwa M; Kondo S; Sakuragawa N; Koide T
    Thromb Res; 1984 Dec; 36(6):633-42. PubMed ID: 6084876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.